These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16869738)

  • 1. High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors.
    Hicks J; Muthuswamy L; Krasnitz A; Navin N; Riggs M; Grubor V; Esposito D; Alexander J; Troge J; Wigler M; Maner S; Lundin P; Zetterberg A
    Cold Spring Harb Symp Quant Biol; 2005; 70():51-63. PubMed ID: 16869738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel patterns of genome rearrangement and their association with survival in breast cancer.
    Hicks J; Krasnitz A; Lakshmi B; Navin NE; Riggs M; Leibu E; Esposito D; Alexander J; Troge J; Grubor V; Yoon S; Wigler M; Ye K; Børresen-Dale AL; Naume B; Schlicting E; Norton L; Hägerström T; Skoog L; Auer G; Månér S; Lundin P; Zetterberg A
    Genome Res; 2006 Dec; 16(12):1465-79. PubMed ID: 17142309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
    Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
    Cancer Res; 2001 Feb; 61(3):1214-9. PubMed ID: 11221853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of 20q13 gain by dual-color FISH in breast cancers.
    Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
    Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH cytogenetics and prognosis in breast and non-small cell lung cancers.
    Massoner A; Augustin F; Duba HC; Zojer N; Fiegl M
    Cytometry B Clin Cytom; 2004 Nov; 62(1):52-6. PubMed ID: 15468329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood mononuclear cells are a reliable internal standard for the flow cytometric DNA analysis of frozen malignant breast biopsies.
    Benn DE; Robinson BG
    Cytometry; 1996 Jun; 26(2):161-5. PubMed ID: 8817093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated profiling of basal and luminal breast cancers.
    Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
    Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ; Marnay J; Plancoulaine B; Chasle J
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
    Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
    Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array-CGH and breast cancer.
    van Beers EH; Nederlof PM
    Breast Cancer Res; 2006; 8(3):210. PubMed ID: 16817944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
    Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
    Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
    Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
    Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
    Buness A; Kuner R; Ruschhaupt M; Poustka A; Sültmann H; Tresch A
    Bioinformatics; 2007 Sep; 23(17):2273-80. PubMed ID: 17599933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics in breast cancer-therapeutic implications.
    Lønning PE; Sørlie T; Børresen-Dale AL
    Nat Clin Pract Oncol; 2005 Jan; 2(1):26-33. PubMed ID: 16264853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.